Search
Search
About
Log in
Join
Experiences with
Ibrutinib
Posts
Communities
1,999 public posts
Filter results
Avoiding Chemotherapy.
THIS is one reason why we need, and should push NICE, for the newer drugs such as
ibrutinib
. While the longer term effects of
ibrutinib
are not yet known, the damage to our genome is certainly less. Dick
THIS is one reason why we need, and should push NICE, for the newer drugs such as
ibrutinib
. While the longer term effects of
ibrutinib
are not yet known, the damage to our genome is certainly less. Dick
Kwenda
in
CLL Support
11 years ago
Interview with Dr. Adrian Wiestner from the NIH on his Research on Ibrutinib
Wiestner on his research on
ibrutinib
. His interviews will be the last from ASH 2012, as I look forward to going to ASCO 2013 and learning and sharing from that. Things are moving fast. Please take a look at http://bkoffman.blogspot.com and learn from Dr.
Wiestner on his research on
ibrutinib
. His interviews will be the last from ASH 2012, as I look forward to going to ASCO 2013 and learning and sharing from that. Things are moving fast. Please take a look at http://bkoffman.blogspot.com and learn from Dr.
bkoffman
CLL CURE Hero
in
CLL Support
11 years ago
Video, Dr. Jennifer Brown.... ibrutinib, idelalisib, and other agents.
Jennifer Brown, MD, PhD, Director, Chronic Lymphocytic Leukemia Center, Dana-Farber Cancer Institute, Assistant Professor of Medicine, Harvard Medical School, discusses the treatment of chronic lymphocytic leukemia with
ibrutinib
, idelalisib, etc. http://tinyurl.com/ct7erqs
Jennifer Brown, MD, PhD, Director, Chronic Lymphocytic Leukemia Center, Dana-Farber Cancer Institute, Assistant Professor of Medicine, Harvard Medical School, discusses the treatment of chronic lymphocytic leukemia with
ibrutinib
, idelalisib, etc. http://tinyurl.com/ct7erqs
Cllcanada
Top Poster CURE Hero
in
CLL Support
11 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Clonal evolution, genomic drivers and effects of therapy in CLL
Karl Schwartz of Lymphomation.org has recently raised the important question of whether using drugs like
ibrutinib
to keep a lid on CLL might give a longer life expectancy than more traditional treatments that are likely to drive clonal evolution.
Karl Schwartz of Lymphomation.org has recently raised the important question of whether using drugs like
ibrutinib
to keep a lid on CLL might give a longer life expectancy than more traditional treatments that are likely to drive clonal evolution.
AussieNeil
Partner
in
CLL Support
11 years ago
Pharmacylics have closed their first Phase III Ibrutinib trial with 350 patients
The Wall Street Journal reports that Pharmacylics today announced that the enrollment target of 350 patients for its Phase III study using
ibrutinib
monotherapy versus ofatumumab in patients with relapsed or refractory CLL/SLL, has been achieved ahead of schedule and enrollments are now officially closed
The Wall Street Journal reports that Pharmacylics today announced that the enrollment target of 350 patients for its Phase III study using
ibrutinib
monotherapy versus ofatumumab in patients with relapsed or refractory CLL/SLL, has been achieved ahead of schedule and enrollments are now officially closed
AussieNeil
Partner
in
CLL Support
11 years ago
Pharmacyclics presents positive results of ibrutinib Phase II trial in untreated, relapsed and refractory CLL patients
http://www.news-medical.net/news/20130411/Pharmacyclics-presents-positive-results-of-
ibrutinib
-Phase-II-trial-in-untreated-relapsed-and-refractory-CLL-patients.aspx Some quotes: "
Ibrutinib
was highly efficacious as a single agent in patients with untreated, relapsed and unresponsive CLL, irrespective
http://www.news-medical.net/news/20130411/Pharmacyclics-presents-positive-results-of-
ibrutinib
-Phase-II-trial-in-untreated-relapsed-and-refractory-CLL-patients.aspx Some quotes: "
Ibrutinib
was highly efficacious as a single agent in patients with untreated, relapsed and unresponsive CLL, irrespective
AussieNeil
Partner
in
CLL Support
11 years ago
Ibrutinib, one of the new CLL drugs.
Forbes magazine has an article on
ibrutinib
, one of the new drugs for CLL. Being Forbes magazine there is much detail about how the drug research and development was funded, but it’s still an interesting read.
Forbes magazine has an article on
ibrutinib
, one of the new drugs for CLL. Being Forbes magazine there is much detail about how the drug research and development was funded, but it’s still an interesting read.
Kwenda
in
CLL Support
11 years ago
Ibrutinib...FDA 'Breakthrough Therapy' for CLL/SLL ---- 17p deleted only
Food and Drug Administration (FDA) has granted an additional Breakthrough Therapy Designation for the investigational oral agent
ibrutinib
as monotherapy for the treatment of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) patients with deletion of the short arm of chromosome 17
Food and Drug Administration (FDA) has granted an additional Breakthrough Therapy Designation for the investigational oral agent
ibrutinib
as monotherapy for the treatment of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) patients with deletion of the short arm of chromosome 17
Cllcanada
Top Poster CURE Hero
in
CLL Support
11 years ago
Dr. Richard Furman InterviewASH 2012
Furman on his experience with
ibrutinib
and idelasilib (GS-1101), what is known, what isn't, and what the future might hold.
Furman on his experience with
ibrutinib
and idelasilib (GS-1101), what is known, what isn't, and what the future might hold.
bkoffman
CLL CURE Hero
in
CLL Support
11 years ago
ASH 2012 Interview with Dr. Rick Furman
This is one of my favorite interviews as it tells the story of the phase 1 trials of
ibrutinib
and idelalisib (CAL 101) by Dr. Furman who was the investigator for them both. See http://bkoffman.blogspot.com
This is one of my favorite interviews as it tells the story of the phase 1 trials of
ibrutinib
and idelalisib (CAL 101) by Dr. Furman who was the investigator for them both. See http://bkoffman.blogspot.com
bkoffman
CLL CURE Hero
in
CLL Support
12 years ago
Saying No to Chemo. Part 1
On a personal note, I am continuing to do well on my
ibrutinib
trial. Thanks and be well Brian
On a personal note, I am continuing to do well on my
ibrutinib
trial. Thanks and be well Brian
bkoffman
CLL CURE Hero
in
CLL Support
12 years ago
News about the new drugs being trialled for CLL.
Plus several long articles about the newer drugs such as
Ibrutinib
with comments from Claire Dearden, MD, the head of the CLL Unit at the Royal Marsden Hospital in London.
Plus several long articles about the newer drugs such as
Ibrutinib
with comments from Claire Dearden, MD, the head of the CLL Unit at the Royal Marsden Hospital in London.
Kwenda
in
CLL Support
12 years ago
Hi everyone , how far do you think we are away from not using FCR has the first line treatment , and drugs such as ibrutinib or cal - 101
I know some
ibrutinib
trials has began in the uk also consultants going through NICE to make this drug available to some patients Stewie Watch and wait Student nurse
I know some
ibrutinib
trials has began in the uk also consultants going through NICE to make this drug available to some patients Stewie Watch and wait Student nurse
stewie
in
CLL Support
12 years ago
ASH 2012 Interviews Part 3 Dr. John Byrd on Ibrutinib
Byrd where he discusses some of the details of what we know about
ibrutinib
therapy so far.
Byrd where he discusses some of the details of what we know about
ibrutinib
therapy so far.
bkoffman
CLL CURE Hero
in
CLL Support
12 years ago
Interview with Dr. Byrd at ASH 2012 on new medications, especially ibrutinib
Hi, Dr Byrd is my physician at OSU and arguably has more clinical experience with
ibrutinib
than anyone else in the world. On my blog ( http://bkoffman.blogspot.com ) tonight, I posted the first of a 4 part interview done at ASH 2012. It's 10 minutes well spent.
Hi, Dr Byrd is my physician at OSU and arguably has more clinical experience with
ibrutinib
than anyone else in the world. On my blog ( http://bkoffman.blogspot.com ) tonight, I posted the first of a 4 part interview done at ASH 2012. It's 10 minutes well spent.
bkoffman
CLL CURE Hero
in
CLL Support
12 years ago
New prognostic markers and better understanding of risk groups?
ABT-199,
ibrutinib
, CAL-101, GA-101 .Will traditional markers hold up in the "new era?" There are many questions.
ABT-199,
ibrutinib
, CAL-101, GA-101 .Will traditional markers hold up in the "new era?" There are many questions.
HAIRBEAR_UK
Administrator
in
CLL Support
12 years ago
CLL patient advocate and journalist, Andrew Schorr shares his story with CLL patient Dr Brian Koffman from the other side of the lens.
feature=player_embedded&v=S-3tqTQEvJk In Future posts Dr Brian Koffman will share the interview Andrew Schorr did with him at ASH about his
ibrutinib
trial.
feature=player_embedded&v=S-3tqTQEvJk In Future posts Dr Brian Koffman will share the interview Andrew Schorr did with him at ASH about his
ibrutinib
trial.
HAIRBEAR_UK
Administrator
in
CLL Support
12 years ago
More from ASH about some of the novel therapies in trial
Ibrutinib
, GS 1101 and ABT-199 are changing the CLL treatment landscape, plus antibody therapies such as GA 101 and novel therapies such as TRUO16 and the exciting T cell mediated therapies in research CART etc. All of these are moving away from toxicity treatments for the future.
Ibrutinib
, GS 1101 and ABT-199 are changing the CLL treatment landscape, plus antibody therapies such as GA 101 and novel therapies such as TRUO16 and the exciting T cell mediated therapies in research CART etc. All of these are moving away from toxicity treatments for the future.
HAIRBEAR_UK
Administrator
in
CLL Support
12 years ago
ASH 2012 Ibrutinib Press Conference
Patient Power Video http://www.patientpower.info/video/results-suggest-a-potential-breakthrough-in-cll?autoplay=1
Patient Power Video http://www.patientpower.info/video/results-suggest-a-potential-breakthrough-in-cll?autoplay=1
Cllcanada
Top Poster CURE Hero
in
CLL Support
12 years ago
1
...
99
100
60
70
80
90
100
Filter results
Clear filters
Posted in
All communities
CLL Support
1909 results
CLL America Support
29 results
Non Hodgkin's Lymphoma Friends
29 results
View top 10 communities
Sort by
Most Relevant
Newest